Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
RSPH
63
HOLDINGS
12%
ALSO IN XPH
XPH
60
HOLDINGS
12%
ALSO IN RSPH
SECTOR DRIFT (RSPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in RSPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 1.8% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 2.0% | 1.7% | 1.7% |
|
MERCK & CO. INC. | 2.1% | 1.7% | 1.7% |
|
VIATRIS, INC. | 2.3% | 1.7% | 1.7% |
|
ELI LILLY & CO | 2.2% | 1.6% | 1.6% |
RSPH Overweight Relative to XPH
|
MODERNA, INC. | 4.0% |
|
CENTENE CORP | 3.0% |
|
DAVITA INC | 2.4% |
|
CARDINAL HEALTH INC | 2.3% |
|
BIOGEN IDEC INC | 2.1% |
|
ALIGN TECHNOLOGY INC | 2.1% |
|
CVS CAREMARK CORP | 2.0% |
|
HUMANA INC | 2.0% |
|
WEST PHARMACEUTICAL SERVICES | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
RSPH Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.0% |
|
DEFINIUM THERAPEUTICS INC | -2.8% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
NUVATION BIO INC CLASS A | -2.1% |
|
ALUMIS INC | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.0% |
|
TREVI THERAPEUTICS, INC. | -2.0% |
|
EDGEWISE THERAPEUTICS, INC. | -1.9% |